The board of directors of Hoth Therapeutics, a publicly traded company in the United States, approved the purchase of 1 million USD worth of Bitcoin as reserve assets.
PANews, November 20, reported by PR Newswire, that the U.S. publicly traded company Hoth Therapeutics, Inc. (NASDAQ: HOTH) announced that its board of directors has approved the purchase of up to 1 million USD in Bitcoin. Hoth CEO Robb Knie stated: "With the ongoing growth of Bitcoin and its emergence as a major asset class attracting investor attention and recognition, we believe Bitcoin will become a strong financial reserve asset. With the recent approval of Bitcoin ETFs and the increasing activity of institutional investors, Bitcoin will be a powerful addition to our financial strategy. We believe that Bitcoin's anti-inflation properties may make it a reliable asset with value storage capabilities."
According to reports, Acurx Pharmaceuticals is a biopharmaceutical company. Previously, another biopharmaceutical company, Acurx Pharmaceuticals, announced that its board of directors approved the purchase of 1 million USD in Bitcoin as a reserve asset.
PANews, November 20, reported by PR Newswire, that the U.S. publicly traded company Hoth Therapeutics, Inc. (NASDAQ: HOTH) announced that its board of directors has approved the purchase of up to 1 million USD in Bitcoin. Hoth CEO Robb Knie stated: "With the ongoing growth of Bitcoin and its emergence as a major asset class attracting investor attention and recognition, we believe Bitcoin will become a strong financial reserve asset. With the recent approval of Bitcoin ETFs and the increasing activity of institutional investors, Bitcoin will be a powerful addition to our financial strategy. We believe that Bitcoin's anti-inflation properties may make it a reliable asset with value storage capabilities."
According to reports, Acurx Pharmaceuticals is a biopharmaceutical company. Previously, another biopharmaceutical company, Acurx Pharmaceuticals, announced that its board of directors approved the purchase of 1 million USD in Bitcoin as a reserve asset.
The board of directors of Hoth Therapeutics, a publicly traded company in the United States, approved the purchase of 1 million USD worth of Bitcoin as reserve assets.
PANews, November 20, reported by PR Newswire, that the U.S. publicly traded company Hoth Therapeutics, Inc. (NASDAQ: HOTH) announced that its board of directors has approved the purchase of up to 1 million USD in Bitcoin. Hoth CEO Robb Knie stated: "With the ongoing growth of Bitcoin and its emergence as a major asset class attracting investor attention and recognition, we believe Bitcoin will become a strong financial reserve asset. With the recent approval of Bitcoin ETFs and the increasing activity of institutional investors, Bitcoin will be a powerful addition to our financial strategy. We believe that Bitcoin's anti-inflation properties may make it a reliable asset with value storage capabilities."
According to reports, Acurx Pharmaceuticals is a biopharmaceutical company. Previously, another biopharmaceutical company, Acurx Pharmaceuticals, announced that its board of directors approved the purchase of 1 million USD in Bitcoin as a reserve asset.
PANews, November 20, reported by PR Newswire, that the U.S. publicly traded company Hoth Therapeutics, Inc. (NASDAQ: HOTH) announced that its board of directors has approved the purchase of up to 1 million USD in Bitcoin. Hoth CEO Robb Knie stated: "With the ongoing growth of Bitcoin and its emergence as a major asset class attracting investor attention and recognition, we believe Bitcoin will become a strong financial reserve asset. With the recent approval of Bitcoin ETFs and the increasing activity of institutional investors, Bitcoin will be a powerful addition to our financial strategy. We believe that Bitcoin's anti-inflation properties may make it a reliable asset with value storage capabilities."
According to reports, Acurx Pharmaceuticals is a biopharmaceutical company. Previously, another biopharmaceutical company, Acurx Pharmaceuticals, announced that its board of directors approved the purchase of 1 million USD in Bitcoin as a reserve asset.
